| Factor Information | |
|---|---|
| Data ID | 2245 |
| Factor | CPB(cardiopulmonary bypass) time(min) |
| Description | Both groupswere comparable except for age, which was younger in the study group, and cardiopulmonary by passt ime, which was longer in the studygroup. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | The purpose of this study was to evaluate survival outcomes after heart transplantation in a contemporary cohort of adults with CHD and to identify risk factors for mortality that may help guide recipient and donor selection. |
| p Value | <0.001 |
| Conclusion | Both groups were comparable except for age, which was younger in the study group, and cardiopulmonary by passt ime, which was longer in the studygroup. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 593 |
| CHD Type | isolated CHD |
| CHD Subtype | TGA/VSD/ASD/TOF/other |
| Reference | |
|---|---|
| PMID | 23474360 |
| Year | 2013 |
| Title | Heart transplantation for adults with congenital heart disease: results in the modern era. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | Database | |
| Region | Pennsylvania,USA | |
| Method | a retrospective analysis | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | Heart transplantation(HT) | |
| Group | CHD(Treatment) | Controls(Control) |
| Number | 19 | 428 |
| Age | 39.4 ± 13 years | 54.7 ± 12 years |
| Gender (Male: Female) | 12:7 | 320:108 |
| Marker Level | 235 ± 68 min | 185 ± 55 min |
